Vertex Pharmaceuticals Q2 Adj $(12.83) Misses $4.14 Estimate, Sales $2.65B Miss $2.66B Estimate

Author: Benzinga Newsdesk | August 01, 2024 04:06pm
Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly losses of $(12.83) per share which missed the analyst consensus estimate of $4.14 by 409.9 percent. This is a 429.82 percent decrease over earnings of $3.89 per share from the same period last year. The company reported quarterly sales of $2.65 billion which missed the analyst consensus estimate of $2.66 billion by 0.53 percent. This is a 6.14 percent increase over sales of $2.49 billion the same period last year.

Posted In: VRTX